Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
published in: Journal of Hepatology
date of publication: 2017-07-04
main subject: hepatocellular carcinoma
Cites articles
There is nothing here
Article - wd:Q40131537